Merit Medical Systems Inventory 2010-2024 | MMSI

Merit Medical Systems inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
  • Merit Medical Systems inventory for the quarter ending September 30, 2024 was $0.311B, a 2.17% increase year-over-year.
  • Merit Medical Systems inventory for 2023 was $0.304B, a 14.24% increase from 2022.
  • Merit Medical Systems inventory for 2022 was $0.266B, a 19.86% increase from 2021.
  • Merit Medical Systems inventory for 2021 was $0.222B, a 12.07% increase from 2020.
Merit Medical Systems Annual Inventory
(Millions of US $)
2023 $304
2022 $266
2021 $222
2020 $198
2019 $226
2018 $198
2017 $155
2016 $121
2015 $106
2014 $92
2013 $82
2012 $85
2011 $70
2010 $61
2009 $47
Merit Medical Systems Quarterly Inventory
(Millions of US $)
2024-09-30 $311
2024-06-30 $298
2024-03-31 $303
2023-12-31 $304
2023-09-30 $304
2023-06-30 $306
2023-03-31 $290
2022-12-31 $266
2022-09-30 $247
2022-06-30 $233
2022-03-31 $231
2021-12-31 $222
2021-09-30 $208
2021-06-30 $195
2021-03-31 $200
2020-12-31 $198
2020-09-30 $209
2020-06-30 $221
2020-03-31 $228
2019-12-31 $226
2019-09-30 $217
2019-06-30 $203
2019-03-31 $199
2018-12-31 $198
2018-09-30 $181
2018-06-30 $169
2018-03-31 $167
2017-12-31 $155
2017-09-30 $146
2017-06-30 $137
2017-03-31 $134
2016-12-31 $121
2016-09-30 $117
2016-06-30 $110
2016-03-31 $111
2015-12-31 $106
2015-09-30 $100
2015-06-30 $93
2015-03-31 $88
2014-12-31 $92
2014-09-30 $93
2014-06-30 $86
2014-03-31 $85
2013-12-31 $82
2013-09-30 $81
2013-06-30 $82
2013-03-31 $82
2012-12-31 $85
2012-09-30 $79
2012-06-30 $71
2012-03-31 $70
2011-12-31 $70
2011-09-30 $67
2011-06-30 $63
2011-03-31 $60
2010-12-31 $61
2010-09-30 $58
2010-06-30 $47
2010-03-31 $47
2009-12-31 $47
2009-09-30 $48
2009-06-30 $46
2009-03-31 $43
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.988B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71